Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Summary of Important Points

Discovery Preclinical Clinical Regulatory Application Approval [Pg.16]

The overall process takes 10-12 years and costs more than US 1 billion. [Pg.16]

Regulatory oversight is an integral part of the pharmaceutical industry, in order to ensure safety, efficacy, purity, and consistency of drugs for human use. [Pg.16]

The global pharmaceutical market in 2006 was US 643 billion. Biopharmaceuticals account for more than 10% of the market, with higher growth rate compared to conventional pharmaceuticals. [Pg.16]

The top-selling drug in 2007 was Lipitor with about US 12 billion in sales and the top biopharmaceutical was Enbrel, which brings in about US 2.5 billion revenue. [Pg.16]

This second edition has been completely revised to include the latest advances in drug discovery, development, clinical trials, manufacturing, and regulatory processes. At the end of each chapter is a case study to provide more in-depth perspectives and current issues facing the pharmaceutical industry. A summary of important points and questions and answers are added to each chapter for reference. [Pg.481]

Xd>ie 1-3-2. Summary of Important Points About Transcription and RNA Processing... [Pg.39]

See other pages where Summary of Important Points is mentioned: [Pg.1]    [Pg.16]    [Pg.20]    [Pg.50]    [Pg.54]    [Pg.88]    [Pg.94]    [Pg.131]    [Pg.131]    [Pg.137]    [Pg.171]    [Pg.171]    [Pg.177]    [Pg.204]    [Pg.209]    [Pg.227]    [Pg.227]    [Pg.232]    [Pg.273]    [Pg.273]    [Pg.279]    [Pg.315]    [Pg.315]    [Pg.320]    [Pg.355]    [Pg.355]   


SEARCH



Important Point

Summary Points

© 2024 chempedia.info